30 June,2021 04:59 PM IST | New Delhi | ANI
A vial of Covaxin | File Pic
Results of trials of the third booster dose of Bharat Biotech's Covid-19 vaccine Covaxin is expected to come by November this year, sources told ANI.
The booster dose of the indigenously manufactured vaccine was first launched in May, after which the trials began at the All India Institute of Medical Sciences (AIIMS) in Delhi and Patna. As many as 12 centres across the country are conducting trials for Covaxin's booster shot.
The permission to conduct the clinical trials for the third booster dose was granted to Bharat Biotech in April by the Drug Controller General of India (DCGI). The results of the first trial, conducted in May, will come in August.
Meanwhile, for the second trial, final results are expected by November 2021. The trials are aimed at assessing the immunogenicity, safety, reactogenicity and tolerability of the Covaxin booster dose.
ALSO READ
RFK Jr says he's resigned from anti-vaccine nonprofit as he seeks nation's top health official job
TMC chief calls for strict implementation 'ease of living' action plan
HMPV scare: No cause for concern, says Maharashtra Health Minister
HMPV scare: Expected during winter, says WHO official
HMPV outbreak: Suspected case detected in Sabarkantha district of Gujarat
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
